Byotrol PLC operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Byotrol PLC with three other
pharmaceutical manufacturers in Europe:
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
sales of 20.47 million Turkish Liras [US$3.65 million]
(26.02 million Danish Kroner [US$3.88 million]
of which 36%
was Antibodies), and
Premier Veterinary Group PLC
(£3.15 million [US$3.80 million]
of which 63%
was PPCP UK).
During the year ended March of 2018, sales at
Byotrol PLC were £3.14 million (US$3.79 million).
a very small
increase of 0.4%
versus 2017, when the company's sales were £3.13 million.
Sales of Consumer saw an increase
that was more than double the company's growth rate: sales were up
29.5% in 2018, from
£1.15 million to £1.49 million.
Not all segments of Byotrol PLC experienced an increase in sales in 2018:
sales of Professional fell 22.4% to £916,520.00 .
Byotrol PLC also experienced decreases in sales in
Pet (down 8.0% to £730,786.00 )